- Nadish Garg, MD, FASE, FACC
- Phone: 832-328-8551
- Mon-Fri (8:30am - 5pm)
- Patient Portal
MitraClip is a medical device used to treat a condition called mitral regurgitation (MR). MR is a heart valve disorder in which the mitral valve does not close properly, causing blood to flow backward into the left atrium when the heart contracts. This results in a decreased efficiency of blood flow and can lead to symptoms such as shortness of breath, fatigue, and heart failure.
The MitraClip device is designed to provide a minimally invasive treatment option for patients with significant MR who are not suitable candidates for traditional open-heart surgery. It is considered a transcatheter mitral valve repair (TMVR) procedure, meaning it is performed using catheters threaded through blood vessels, usually from the groin, to reach the heart.
Here's how the MitraClip procedure works:
MitraClip for Mitral Valve Regurgitation
- Insertion: A thin, flexible tube called a catheter is inserted into a blood vessel, typically in the groin, and guided to the heart.
- Placement: The MitraClip device, which resembles a small metal clip, is attached to the end of the catheter. The catheter is then maneuvered to the mitral valve.
- Clipping: Once the catheter is in the appropriate position, the MitraClip is carefully guided to the site of the mitral valve leaflets, which are the flaps of tissue that form the valve. The clip is used to grasp and bring together the edges of the valve leaflets to reduce the backflow of blood when the heart contracts.
- Assessment: The clip's position and effectiveness in reducing mitral regurgitation are evaluated through imaging tests, such as echocardiography, during the procedure.
- Final adjustments: If necessary, the clip's position can be adjusted or additional clips may be used to optimize the results.
MitraClip is a relatively less invasive option compared to open-heart surgery for treating significant mitral regurgitation, especially in high-risk or inoperable patients. It can improve symptoms and quality of life for those with MR, and some studies have shown positive long-term outcomes. However, not all patients are suitable candidates for MitraClip, and the decision on the most appropriate treatment approach depends on various factors, including the patient's overall health, the severity of mitral regurgitation, and the anatomy of the mitral valve. As with any medical procedure, there are potential risks and benefits that should be carefully considered and discussed between the patient and their medical team.